Your session is about to expire
← Back to Search
Behavioural Intervention
mymobility App + Apple Watch for Osteoarthritis Recovery
N/A
Waitlist Available
Research Sponsored by Zimmer Biomet
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Subject is mobile with no more than a single cane/single crutch assist preoperatively
Subject must be 18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if a smartphone app and fitness trackers can help patients recover better after knee or hip replacement surgeries compared to traditional physical therapy.
Who is the study for?
Adults over 18 needing a primary knee arthroplasty, who can walk with minimal assistance and own an iPhone compatible with the mymobility App. They must be able to understand the app's language and consent to participate. Excluded are those with systemic inflammatory diseases, current substance abuse issues, or involvement in other related studies.
What is being tested?
The study is testing if using the mymobility platform with an Apple Watch for education and exercise guidance can replace or improve upon standard physical therapy after hip or knee replacement surgery.
What are the potential side effects?
Since this trial involves a mobile application and activity monitoring rather than medication, traditional side effects are not applicable. However, participants may experience discomfort from increased activity levels encouraged by the app.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can move around but may need a cane or crutch.
Select...
I am 18 years old or older.
Select...
I am eligible for knee replacement surgery based on my medical history and physical exam.
Select...
I am eligible for knee replacement surgery based on my medical history and physical exam.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Phase II (RCT): Readmission Rate
Secondary study objectives
Phase II RCT: EQ-5D-5L
Phase II RCT: Healthcare Costs
Phase II RCT: Hip disability and Osteoarthritis Outcome Score - Joint Replacement (HOOS, JR)
+5 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: mymobility with Apple WatchExperimental Treatment1 Intervention
Post-operative mobile application-guided education and exercise paired with accurate and sensitive activity monitoring.
Group II: Standard of Care Physical TherapyActive Control1 Intervention
Standard of care patient education and post-operative physical therapy, as determined by local site guidelines and care pathways.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for osteoarthritis (OA) include analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), and exercise therapy. Analgesics like acetaminophen work by reducing pain signals in the brain, while NSAIDs such as ibuprofen and naproxen reduce inflammation and pain by inhibiting enzymes involved in the inflammatory process.
Exercise therapy, particularly when guided by mobile applications and monitored through wearables, improves pain and function by enhancing muscle strength, joint stability, and overall physical fitness. This approach also provides real-time feedback and personalized adjustments, which can help patients adhere to their exercise regimens more effectively.
Understanding these mechanisms is crucial for OA patients as it empowers them to actively participate in their treatment, potentially leading to better pain management and improved quality of life.
Find a Location
Who is running the clinical trial?
Zimmer BiometLead Sponsor
375 Previous Clinical Trials
57,517 Total Patients Enrolled
135 Trials studying Osteoarthritis
24,187 Patients Enrolled for Osteoarthritis
Erin OsbornStudy DirectorZimmer Biomet
13 Previous Clinical Trials
2,304 Total Patients Enrolled
5 Trials studying Osteoarthritis
1,503 Patients Enrolled for Osteoarthritis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My treatment includes a device that will be used as the manufacturer intended.I am willing and able to follow the study's required check-ups and procedures.I can move around but may need a cane or crutch.You are able to read and understand the language used in the mymobility App for your region.I am 18 years old or older.I need both of my joints replaced, either at the same time or within 90 days of each other.I am eligible for knee replacement surgery based on my medical history and physical exam.I am eligible for knee replacement surgery based on my medical history and physical exam.I am 18 years old or older.You are willing and able to provide written Informed Consent and Authorization by signing and dating the IRB/EC approved Informed Consent Form and Authorization.You are currently using alcohol or drugs in a way that is considered harmful or addictive.I have a condition like arthritis that could affect the study results.
Research Study Groups:
This trial has the following groups:- Group 1: mymobility with Apple Watch
- Group 2: Standard of Care Physical Therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Osteoarthritis Patient Testimony for trial: Trial Name: NCT03737149 — N/A
Share this study with friends
Copy Link
Messenger